M1 Kliniken AG Reports Strong Growth in Beauty Segment for H1 2026

Berlin, 9 September 2026 – M1 Kliniken AG has published its half-year report for 2026, showcasing significant growth in its Beauty segment. With revenues up by 11.0% to EUR 56.9 million, the segment's EBIT rose by 23.8% to EUR 18.6 million. This rise marks a notable increase in the EBIT margin to 32.7%, surpassing the group's target of at least 20%.

Despite a considerable drop in group revenue to EUR 76.6 million following the sale of HAEMATO Pharm GmbH, the group's earnings before taxes nearly matched the previous year at EUR 16.0 million. A one-off deconsolidation effect impacted reported EBIT, but adjusted figures show an increase to EUR 19.7 million.

M1 Kliniken AG aims for rapid expansion, targeting EUR 200 to 300 million revenue in the Beauty segment by 2029. The group's focus remains on establishing itself as a global leader in aesthetic medicine.